ESMO announces new Editor-in-Chief of Annals of Oncology
We are pleased to announce that Professor Jean-Charles Soria, MD, PhD will be the new Editor-in-Chief of Annals of Oncology as of January 2014.
ESMO Media Releases
ESMO bestows its highest accolades to eminent oncologists
We are pleased to announce the winners of the 2013 ESMO Awards!
ESMO Announces President for the Years 2016-2017
The ESMO Nominating Committee announces the results of the recent election for our President 2016-2017.
Immune-Boosting Colorectal Cancer Drug Shows Promise
World GI 2013 Press Release: Immune-Boosting Colorectal Cancer Drug Shows Promise
Study Confirms Adding Chemotherapy to Surgery Improves Survival in Advanced Gastric Cancer
World GI 2013 Press Release: Study Confirms Adding Chemotherapy to Surgery Improves Survival in Advanced Gastric Cancer
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer
Study Opens New Prospects for Developing Dew Targeted Therapies for Breast Cancer
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Study confirms Everolimus can overcome Trastuzumab resistance in IN HER-2 positive early breast cancer
A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.
Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence
Study reveals magnitude of variation in gene expression measurements within breast cancers
An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.
Breast cancer heterogeneity no barrier to predictive testing, study shows
Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients.